Seeking Consumer-centric Solutions for Digital Therapeutics

Keywords
Digital therapeutics, DTx, CBT, cognitive behavioral therapy, chronic disease, chronic conditions, chronic pain

Organisation
Reckitt Benckiser

Background

Digital Therapeutics (DTx) are evidence-based health interventions driven by software programmes. DTx can also be a part of an adjunctive solution combining a software-based solution with traditional medicinal products – levelling up consumer outcomes. It is an emerging space but has seen significant growth with multiple regulatory approved products already available in the market.

We seek software-based solutions (apps, web-based solutions, voice apps etc.) that either: 

  1. Directly contributes to the therapy or treatment a consumer is undergoing for a particular condition or disease, or
  2. Can be combined with an OTC medicinal intervention to create significantly improved outcomes for the consumer

Specifications

Solutions are intended for consumer use (i.e., user who suffers from a condition / disease that is treatable with digital therapy) and portable and convenient forms that can be used on-the-go are preferred. 

Solutions must have strong clinical evidence to back up their efficacy claims and should address the following areas of interest: 

  • Sleep,
  • Mental wellbeing,
  • Sexual Health,
  • Gastrointestinal conditions, and
  • Pain relief

Avoiding

Products with associated hardware devices (digital inhaler, blood glucose monitors etc.)